Tuesday, April 12, 2022 8:38:51 AM
LOL....So you didn't even read the article that you posted twice.
Did you read the financials? Just kidding I dont care....
Boston globe hahahahaha
MRMD doesn't care either, especially about the Boston globe news rag.... neither do actual customers
2022 FINANCIAL TARGETS
Considering MariMed’s strategic plan to drive long-term growth, recent acquisitions, license wins, and current industry dynamics, the Company has set the following financial targets for the full fiscal year 2022:
Revenue of $145 to 150 million.
Adjusted EBITDA of $47 to $52 million.
CAPEX spend of approximately $25 million
“After setting financial targets in 2021 for the first time, and subsequently raising and beating them, I am pleased to announce very strong financial growth targets for 2022,” said Jon Levine, Chief Financial Officer of MariMed. “Our strict financial discipline combined with our outstanding operations give us confidence we will meet or beat our full year financial guidance once again in 2022.”
Did you read the financials? Just kidding I dont care....
Boston globe hahahahaha
MRMD doesn't care either, especially about the Boston globe news rag.... neither do actual customers
2022 FINANCIAL TARGETS
Considering MariMed’s strategic plan to drive long-term growth, recent acquisitions, license wins, and current industry dynamics, the Company has set the following financial targets for the full fiscal year 2022:
Revenue of $145 to 150 million.
Adjusted EBITDA of $47 to $52 million.
CAPEX spend of approximately $25 million
“After setting financial targets in 2021 for the first time, and subsequently raising and beating them, I am pleased to announce very strong financial growth targets for 2022,” said Jon Levine, Chief Financial Officer of MariMed. “Our strict financial discipline combined with our outstanding operations give us confidence we will meet or beat our full year financial guidance once again in 2022.”
Recent MRMD News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 08:30:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2026 08:07:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 09:13:09 PM
- MariMed Reports First Quarter 2026 Earnings • GlobeNewswire Inc. • 05/13/2026 09:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 08:21:20 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/23/2026 08:09:25 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/23/2026 08:06:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 09:18:00 PM
- MariMed Announces First Quarter 2026 Earnings Date • GlobeNewswire Inc. • 04/15/2026 09:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 09:04:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 09:03:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/30/2026 11:43:36 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/12/2026 08:08:14 PM
- MariMed Reports Fourth Quarter and Full Year 2025 Earnings • GlobeNewswire Inc. • 03/11/2026 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 08:11:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 08:09:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 08:08:13 PM
- MariMed Extends Series B Preferred Stock Obligation Through 2031, Strengthening Capital Structure • GlobeNewswire Inc. • 03/02/2026 09:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2026 09:12:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/02/2026 09:03:53 PM
- MariMed Announces Fourth Quarter and Full Year 2025 Earnings Date • GlobeNewswire Inc. • 02/11/2026 12:30:00 PM
- MariMed’s Betty’s Eddies™ Introduces New Limited-Edition Valentine’s Seasonal, Berry In Love Betty • GlobeNewswire Inc. • 02/05/2026 12:00:00 PM
- MariMed Launches Hemp-Derived THC Products Under its Vibations™ Brand in Rhode Island • GlobeNewswire Inc. • 01/22/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/15/2026 09:23:05 PM
- MariMed Statement on Historic Rescheduling of Cannabis • GlobeNewswire Inc. • 12/18/2025 06:52:46 PM
